..................................................
I will delete posts that are
solicitation from a pump site
or solicitation of us by salesmen
..................................................
$NEXCF at resistance $0.88
OTC/QB avg daily volume (low) 16k website hold x 100% sell filings and news 3/27/2020
$6 million in Revenues Period Ended December 31st 2019
$SHMP looking for a bottom $0.027
OTC/QB - made a ton of money the 1st run ($0.02)
Avg daily Volume 440k
Now looking for a bottom play re entry. A Game Changer stock.
Perfected clean "farming" of salt water shrimp and fish. Website float 300.64m
100% sell filings and news 3/18/20 a fire has destroyed the main building
Note:
We are adopting a policy
of barring and deleting paid humps and the like !!
I will delete any paid promo. They come here to make
some use of our casual stock sharing environment.
Good riddance.
Sign in the entrance window:
We will also delete any so-called market research
advertisement or any post fronting such off-site and
any off-site email sign-up or company solicitation.
< All foreign exchange stocks are welcome so long
as their exchange is clearly shown each posting.
A word to the wise:
"Stock picking is work".
"The stock market
is all about work."
"Just you and it "
We follow stocks with a low float < 100M
and stocks with an ultra low float < 30M.
But whatever is moving well, makes a1list.
Charts qualify that are looking up in some way:
on a moving average at resistance or support,
or with a staging formation such as a bull flag.
An upgrading Pr is great too.
The float shown is the highest number
from OTCMarkets-YahooFinance-WSJournal.
I use the highest of any two I look at.
Re: O/S Checked against SEC filings.
Hard Knocks for Doximity Investors Alright, so this isn't the place I usually find myself at that hour, but we're living in wild times if you're clinging to Doximity (NYSE:DOCS) shares. Listen up, because those lawyers are chiming in and they ain't just whistling Dixie. If you bought into DOCS between August 2024 and May 2026 and watched your investment bleed red ink,...
A Shake-Up in Rail Passenger Information Now, here's something from left field that might just have people paying attention while on the go. Teleste, a Finnish company, just put out a gem in rail passenger information systems with the introduction of Acapela's AI-based voice tech into their S-ARRIVE platform. Picture clearer, more natural announcements for every stop,...
Diving Into the M&A Controversy On the bustling streets of New York, beneath the towering Empire State Building, a plot unfolds that could shake the foundations of your investments—particularly if you're holding shares in Synaptics, Eagle Financial, Victory Capital, or Centerspace. Juan Monteverde and his legal firepower from Monteverde & Associates PC are launching a...
A Bold Step Towards Integrity Corruption has long been a thorn in the side of progress for many regions, and watching the Hong Kong International Academy Against Corruption (HKIAAC) step up to the plate in Africa feels like a much-needed move. I mean, when you've got the collective wisdom of folks who've been through the wringer on these issues, you'd be wise to pay heed....
Why Cognizant's Move Matters Imagine being at the top of your game, only to realize you need more heavy-hitters to keep your edge. That’s this deal in a nutshell. Cognizant (NASDAQ: CTSH) is diving deep into AI-led enterprise transformation by scooping up DyFlex Solutions, a name with plenty of clout in the SAP ecosystem. What's Behind the DyFlex Acquisition? Founded in...
A New Pioneer in AI Business Transformation Who would’ve thought two companies merging into one could shake things up this much? Introducing MOOV—a fresh sprout in the Canadian AI scene that's setting out to redefine how businesses across North America get stuff done. By blending the robust AI chops of Moov AI with the strategic design finesse of Nurun, this firm’s...
Custom Compounding: A Lifeline for Specific Needs Standard meds can sometimes feel like a one-size-fits-all shirt—sure it fits, but not comfortably for everyone. Enter the world of custom-compounded medications, where pharmacists like Laura Temple in Azle, Texas, create tailor-made solutions for patients. Think of it as fine-tuning the exact gear needed to climb that...
Pounding the ESG Pavement Every now and then, a story pops up that makes you wonder if the finance folks are finally waking up to what's been slap-you-in-the-face obvious: sustainability ain't just a fancy word for do-gooders anymore. It's the real ticket to the future, and WuXi Biologics (2269.HK) just snagged the top-honor Jade Award at The Asset Corporate...
Addressing Critical Needs: Hand to Hold's Mission Now, I don't know about you, but when I hear "NICU," my mind goes straight to the intense pressure and emotional rollercoaster that it signifies for families. Hand to Hold, a nonprofit that’s knee-deep in supporting NICU families, isn’t just sitting on their hands. They're hosting a 2026 National NICU Mental Health...
Highlight Introduces Pulse for Instant Insights Ever find yourself waiting forever for consumer feedback? Well, folks, Highlight's making sure those days are behind us with their new launch: Pulse. They've taken the conventional consumer testing model and flipped it on its head with Highlight Twins. Imagine getting the pulse of your audience in mere seconds, not the...
Definitive Healthcare Honored as a Premier Workplace Definitive Healthcare (NASDAQ: DH), a leading name in healthcare commercial intelligence, has recently earned prestigious recognition as one of the top employers in Boston. Celebrated by Built In’s 2025 Best Places to Work program, this accolade acknowledges businesses that foster exceptional workplace environments....
Euroseas Earnings Report: Highlights and Performance The market loves a good surprise, and Euroseas just tossed a nice one into the mix with their latest earnings. Released February 25, 2026, at 08:00 AM, they’ve performed better than expected, snagging attention from investors ready for a ride. Earnings Overview Let’s cut to the chase: Euroseas reported an earnings...
Introduction to Datroway's Impact on Breast Cancer Treatment AstraZeneca Plc (NASDAQ: AZN) and Daiichi Sankyo have announced remarkable findings from their TROPION-Breast02 Phase 3 trial for the drug Datroway (datopotamab deruxtecan), set to revolutionize the approach to treating triple-negative breast cancer (TNBC). This pharmaceutical collaboration showcases significant...
Compute Exchange Revolutionizes AI Compute Market Dynamics Today marks a significant shift in the way AI compute resources are bought and sold with the introduction of Compute Exchange. This pioneering platform provides the first open exchange specifically designed for GPUs and various other compute resources, addressing the needs of both buyers and sellers in an...
NuZee Inc. Makes Headlines with Strategic Relocation NuZee, Inc. NUZE is witnessing a significant surge in its stock trading activity. The reason behind this movement is the recent announcement of the company relocating its U.S. operations from California to Florida. This strategic decision aims to bolster its operational efficiency and accessibility. Global Expansion...